Wild Ride, page-16

Unless it's booked in accounts receivable it's not truely definitive.

The question is, will alexium turn these trials into paying customers. Once they can prove/show customers receiving monthly commercial quantities of chemicals and ideally NAME the customer, all of their other talk becomes a lot more compelling. By the sounds of it, the mattress manufacturer deal should be nearing this stage (hopefully) and that would then show us the full life cycle of the business negotiation/trial from initial ramp up through to ongoing delivery with a named end user.

Once this has been verified once, when they say trust us about revenue from the other 44 customers, mr market will be much more likely to listen.